ESTRADERM Side Effects

6546460-1 | Abdominal Pain, Abdominal Pain Lower, Abdominal Pain Upper, Abdominal Symptom, Acute Sinusitis, Arthritis, Bladder Disorder, Blood Alkaline Phosphatase Increased, Breast Calcifications
on Jan 14, 2010 Female patient from UNITED STATES , weighting 180.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal pain lower, abdominal pain upper, abdominal symptom, acute sinusitis, arthritis (What is arthritis?), bladder disorder, blood alkaline phosphatase increased, breast calcifications. Estraderm dosage: 0.01 Mg, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), ESTRATEST (Unk) (View Estratest Review and Estratest Label ), NORETHINDRONE MESTRANOL (Unk) (View Norethindrone-mestranol Review and Norethindrone-mestranol Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), ZANTAC (View Zantac Review and Zantac Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

6544718-3 | Arrhythmia, Back Pain, Breast Cancer, Breast Disorder, Breast Reconstruction, Cardiac Disorder, Cardiac Valve Disease, Depression, Face Injury
Patient was taking Estraderm (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), back pain (What is back pain?), breast cancer (What is breast cancer?), breast disorder, breast reconstruction (What is breast reconstruction?), cardiac disorder, cardiac valve disease, depression (What is depression?), face injury on Jan 14, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 198.0 lb, was diagnosed with menopausal symptoms, hypertension, depression (What is depression?), social phobia and. Estraderm dosage: Unk Biw. During the same period patient was treated with PREMPRO (.625/2.5mg Qd) (View Prempro Review and Prempro Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), TAMOXIFEN CITRATE (10mg Bid) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), LOPRESSOR (Unk, Unk) (View Lopressor Review and Lopressor Label ), PROZAC (Unk, Unk) (View Prozac Review and Prozac Label ), CELEXA (View Celexa Review and Celexa Label ), FEMARA (View Femara Review and Femara Label ).

6544717-1 | Angiopathy, Arrhythmia, Asthenia, Biopsy, Breast Calcifications, Breast Cancer Metastatic, Breast Cancer Recurrent, Breast Lump Removal, Breast Mass
Adverse event was reported on Jan 14, 2010 by a Female patient taking Estraderm (View Usage) (Dosage: ) was diagnosed with depression (What is depression?) and. Location: UNITED STATES , weighting 120.0 lb, After Estraderm was administered, patient had the following side effects: angiopathy, arrhythmia (What is arrhythmia?), asthenia, biopsy, breast calcifications, breast cancer metastatic, breast cancer recurrent, breast lump removal, breast mass. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), PREMPRO (Unk, Unk) (View Prempro Review and Prempro Label ), ZOLOFT (25 Mg, Qd) (View Zoloft Review and Zoloft Label ), ALLEGRA (View Allegra Review and Allegra Label ), ARIMIDEX (Unk) (View Arimidex Review and Arimidex Label ), BONIVA (Unk) (View Boniva Review and Boniva Label ). Patient was hospitalized.

6492262-4 | Abdominal Pain Lower, Adenomyosis, Adnexa Uteri Mass, Angiogram Pulmonary, Arteriogram Coronary Abnormal, Arteriosclerosis Coronary Artery, Atrial Fibrillation, Atrophic Vulvovaginitis, Bacterial Test Positive
on Dec 01, 2009 Female patient from UNITED STATES , weighting 145.0 lb, was diagnosed with menopausal symptoms, hot flush and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain lower, adenomyosis, adnexa uteri mass, angiogram pulmonary, arteriogram coronary abnormal, arteriosclerosis coronary artery, atrial fibrillation (What is atrial fibrillation?), atrophic vulvovaginitis, bacterial test positive. Estraderm dosage: Unk, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (70 Mg, Unk) (View Provera Review and Provera Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), PROGESTERONE (View Progesterone Review and Progesterone Label ), FOSAMAX (View Fosamax Review and Fosamax Label ). Patient was hospitalized.


6491238-0 | Acute Myocardial Infarction, Adenoma Benign, Aortic Stenosis, Arachnoid Cyst, Arterial Stenosis, Arteriosclerosis, Breast Calcifications, Breast Cancer, Breast Mass
on Dec 01, 2009 Female patient from UNITED STATES , weighting 205.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). Patient had the following side effects: acute myocardial infarction, adenoma benign, aortic stenosis, arachnoid cyst, arterial stenosis, arteriosclerosis, breast calcifications, breast cancer (What is breast cancer?), breast mass. Estraderm dosage: 0.5 Mg, Unk. During the same period patient was treated with PREMARIN (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), CYCRIN (5 Mg, Unk) (View Cycrin Review and Cycrin Label ), MPA (5 Mg, Unk) (View Mpa Review and Mpa Label ), ZESTRIL (20 Mg, Bid) (View Zestril Review and Zestril Label ), METOPROLOL (50 Mg, Bid) (View Metoprolol Review and Metoprolol Label ), LORTAB (5 Mg, Q4-6h) (View Lortab Review and Lortab Label ), LIPITOR (10 Mg, Qd) (View Lipitor Review and Lipitor Label ). Patient was hospitalized.

6491225-2 | Angiopathy, Asthenia, Biopsy, Breast Calcifications, Breast Cancer Metastatic, Breast Cancer Recurrent, Breast Lump Removal, Breast Mass, Cardiac Disorder
Patient was taking Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: angiopathy, asthenia, biopsy, breast calcifications, breast cancer metastatic, breast cancer recurrent, breast lump removal, breast mass, cardiac disorder on Dec 01, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, was diagnosed with depression (What is depression?) and. Estraderm dosage: . During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), PREMPRO (Unk, Unk) (View Prempro Review and Prempro Label ), ZOLOFT (25 Mg, Qd) (View Zoloft Review and Zoloft Label ), ALLEGRA (View Allegra Review and Allegra Label ), ARIMIDEX (Unk) (View Arimidex Review and Arimidex Label ), BONIVA (Unk) (View Boniva Review and Boniva Label ). Patient was hospitalized.

6490199-8 | Abdominal Pain, Abdominal Pain Lower, Abdominal Pain Upper, Abdominal Symptom, Acute Sinusitis, Arthritis, Bladder Disorder, Blood Alkaline Phosphatase Increased, Breast Calcifications
Adverse event was reported on Dec 01, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.01 Mg, Unk) was diagnosed with menopause (What is menopause?) and. Location: UNITED STATES , weighting 180.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), abdominal pain lower, abdominal pain upper, abdominal symptom, acute sinusitis, arthritis (What is arthritis?), bladder disorder, blood alkaline phosphatase increased, breast calcifications. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), ESTRATEST (Unk) (View Estratest Review and Estratest Label ), NORETHINDRONE MESTRANOL (Unk) (View Norethindrone-mestranol Review and Norethindrone-mestranol Label ), CIMETIDINE (View Cimetidine Review and Cimetidine Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), HYDROCODONE (View Hydrocodone Review and Hydrocodone Label ), ZANTAC (View Zantac Review and Zantac Label ), TAGAMET (View Tagamet Review and Tagamet Label ).

6486572-4 | Angina Pectoris, Aortic Aneurysm, Aortic Aneurysm Repair, Aortic Valve Replacement, Arteriogram Coronary, Arteriosclerosis, Breast Cancer, Breast Cyst, Cardiac Enzymes Increased
on Dec 01, 2009 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with menopause (What is menopause?), depression (What is depression?), hypercholesterolaemia and was treated with Estraderm (View Usage). Patient had the following side effects: angina pectoris, aortic aneurysm (What is aortic aneurysm?), aortic aneurysm repair, aortic valve replacement, arteriogram coronary, arteriosclerosis, breast cancer (What is breast cancer?), breast cyst, cardiac enzymes increased. Estraderm dosage: . During the same period patient was treated with PREMARIN (625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (5 Mg, Unk) (View Provera Review and Provera Label ), AMITRIPTYLINE (Unk, Unk) (View Amitriptyline Review and Amitriptyline Label ), PAXIL (View Paxil Review and Paxil Label ), ZOCOR (40 Mg, Unk) (View Zocor Review and Zocor Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ELAVIL (View Elavil Review and Elavil Label ), CLARITIN (View Claritin Review and Claritin Label ).

6483610-X | Abdominal Pain, Anxiety, Application Site Reaction, Arthritis, Aspiration Biopsy, Bone Giant Cell Tumour, Breast Cancer In Situ, Breast Cancer Recurrent, Breast Cancer Stage I
on Dec 01, 2009 Female patient from UNITED STATES , weighting 135.0 lb, was diagnosed with menopausal symptoms and was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), application site reaction, arthritis (What is arthritis?), aspiration biopsy, bone giant cell tumour, breast cancer in situ, breast cancer recurrent, breast cancer stage i. Estraderm dosage: 0.05 Mg, 2x/wk. During the same period patient was treated with PREMPRO (625/2.5 Mg) (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (5/2.5 Mg Day 1-14) (View Provera Review and Provera Label ), OGEN (View Ogen Review and Ogen Label ), XANAX (View Xanax Review and Xanax Label ), EVISTA (Unk) (View Evista Review and Evista Label ), PROZAC (40 Mg, Unk) (View Prozac Review and Prozac Label ). Patient was hospitalized.

6483608-1 | Alopecia, Anxiety, Arthralgia, Arthritis, Atrial Fibrillation, Back Disorder, Bedridden, Biopsy, Biopsy Breast Abnormal
Patient was taking Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia, anxiety (What is anxiety?), arthralgia, arthritis (What is arthritis?), atrial fibrillation (What is atrial fibrillation?), back disorder, bedridden, biopsy, biopsy breast abnormal on Dec 01, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 193.0 lb, was diagnosed with menopause (What is menopause?) and. Estraderm dosage: Unk, Unk. During the same period patient was treated with PROVERA (Unk, Unk) (View Provera Review and Provera Label ), ADVIL (Unk) (View Advil Review and Advil Label ), ALEVE (Unk) (View Aleve Review and Aleve Label ), ROGAINE (Unk) (View Rogaine Review and Rogaine Label ), PROBIOTICS (MICROORGANISMS W/PROBIOTIC ACTION) (Unk) (View Probiotics (microorganisms W/probiotic Action) Review and Probiotics (microorganisms W/probiotic Action) Label ), PEPCID COMPLETE (Unk) (View Pepcid Complete Review and Pepcid Complete Label ). Patient was hospitalized.

6461770-4 | Anhedonia, Arteriosclerosis, Blood Triglycerides Increased, Breast Calcifications, Breast Cancer In Situ, Breast Lump Removal, Breast Mass, Breast Operation, Burning Sensation
Adverse event was reported on Nov 17, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.1 Mg Twice Weekly) . Location: UNITED STATES , weighting 118.0 lb, Patient had the following side effects: anhedonia, arteriosclerosis, blood triglycerides increased, breast calcifications, breast cancer in situ, breast lump removal, breast mass, breast operation, burning sensation. During the same period patient was treated with VIVELLE (0.05 Mg, Unk) (View Vivelle Review and Vivelle Label ), CYCRIN (2.5 Mg, Unk) (View Cycrin Review and Cycrin Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), PREMPRO (0.625mg/2.5 Mg) (View Prempro Review and Prempro Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), FOSAMAX (35 Mg, Qw) (View Fosamax Review and Fosamax Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), ADVAIR DISKUS 100/50 (View Advair Diskus 100/50 Review and Advair Diskus 100/50 Label ). Patient was hospitalized.

6461754-6 | Abscess Drainage, Anal Fissure, Anorectal Disorder, Anxiety, Appendicectomy, Appendicitis, Benign Breast Neoplasm, Blood Cholesterol Increased, Breast Calcifications
on Nov 17, 2009 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with menopause (What is menopause?), multiple sclerosis (What is multiple sclerosis?), hypoxia and was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: abscess drainage, anal fissure, anorectal disorder, anxiety (What is anxiety?), appendicectomy, appendicitis (What is appendicitis?), benign breast neoplasm, blood cholesterol increased, breast calcifications. Estraderm dosage: . During the same period patient was treated with PREMARIN (0.625 Unk, Unk) (View Premarin Review and Premarin Label ), PREMPRO (View Prempro Review and Prempro Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRATEST (View Estratest Review and Estratest Label ), CYCRIN (View Cycrin Review and Cycrin Label ), ESTRACE (Unk, Qhs) (View Estrace Review and Estrace Label ), STEROIDS NOS (Reported As High Dose) (View Steroids Nos Review and Steroids Nos Label ).

6450556-2 | Abdominal Pain, Back Pain, Basal Cell Carcinoma, Blood Cholesterol Increased, Bone Densitometry, Breast Cancer Stage I, Breast Cancer Stage Ii, Breast Mass, Breast Necrosis
on Nov 09, 2009 Female patient from UNITED STATES , weighting 130.0 lb, was diagnosed with osteoporosis prophylaxis and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), back pain (What is back pain?), basal cell carcinoma, blood cholesterol increased, bone densitometry, breast cancer stage i, breast cancer stage ii, breast mass, breast necrosis. Estraderm dosage: 0.05 Mg, Unk. During the same period patient was treated with PREMPRO (.625/2.5 Mg) (View Prempro Review and Prempro Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), MEDROXYPROGESTERONE (View Medroxyprogesterone Review and Medroxyprogesterone Label ). Patient was hospitalized.

6446425-4 | Arthralgia, Bladder Irritation, Bone Density Decreased, Bone Disorder, Breast Cancer In Situ, Breast Cyst, Breast Mass, Breast Oedema, Breast Tenderness
Patient was taking Estraderm (View Usage). Patient had the following side effects: arthralgia, bladder irritation, bone density decreased, bone disorder, breast cancer in situ, breast cyst, breast mass, breast oedema, breast tenderness on Nov 05, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 126.0 lb, was diagnosed with menopausal symptoms and. Estraderm dosage: 0.5 Mg, Unk. During the same period patient was treated with PREMPRO (View Prempro Review and Prempro Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), PREMARIN (0.625/1.25 Mg) (View Premarin Review and Premarin Label ), PREMPHASE 14/14 (View Premphase 14/14 Review and Premphase 14/14 Label ), ESTROGENS CONJUGATED W/MEDROXYPROGESTERONE (View Estrogens Conjugated W/medroxyprogesterone Review and Estrogens Conjugated W/medroxyprogesterone Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), IMITREX (50 Mg, Unk) (View Imitrex Review and Imitrex Label ).

6444834-0 | Abdominal Distension, Acute Sinusitis, Anxiety, Arthralgia, Atrophy, Back Pain, Breast Cancer, Breast Cancer In Situ, Breast Cyst
Adverse event was reported on Nov 05, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.05 Mg) . Location: UNITED STATES , weighting 160.0 lb, After Estraderm was administered, patient had the following side effects: abdominal distension, acute sinusitis, anxiety (What is anxiety?), arthralgia, atrophy, back pain (What is back pain?), breast cancer (What is breast cancer?), breast cancer in situ, breast cyst. During the same period patient was treated with PREMARIN (.625mg + 0.3mg) (View Premarin Review and Premarin Label ), PROVERA (View Provera Review and Provera Label ), ESTRATEST H.S. (Unk, Unk) (View Estratest H.s. Review and Estratest H.s. Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PREMPRO (.625mg/2.5mg) (View Prempro Review and Prempro Label ), MPA (10mg Qd) (View Mpa Review and Mpa Label ).

6444830-3 | Abdominal Distension, Basal Cell Carcinoma, Breast Calcifications, Breast Cancer Stage I, Breast Mass, Depression, Diverticulum, Gastrooesophageal Reflux Disease, Haemorrhoids
on Nov 05, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with menopause (What is menopause?), osteoporosis (What is osteoporosis?), arthritis (What is arthritis?), hiatus hernia and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, basal cell carcinoma, breast calcifications, breast cancer stage i, breast mass, depression (What is depression?), diverticulum, gastrooesophageal reflux disease, haemorrhoids. Estraderm dosage: 0.05mg Twice Weekly Days 1-25. During the same period patient was treated with PREMPRO (0.625/2.5mg) (View Prempro Review and Prempro Label ), SEX HORMONES AND MODULATORS OF THE GENI. SYS. (View Sex Hormones And Modulators Of The Geni. Sys. Review and Sex Hormones And Modulators Of The Geni. Sys. Label ), CELEBREX (200mg Qd) (View Celebrex Review and Celebrex Label ), RANITIDINE (150mg Unk) (View Ranitidine Review and Ranitidine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIUM (View Calcium Review and Calcium Label ), PROVERA (2.5mg Days 1-25) (View Provera Review and Provera Label ).

6444810-8 | Anxiety, Arthritis, Basal Cell Carcinoma, Biopsy Endometrium, Blood Cholesterol Increased, Blood Triglycerides Increased, Breast Calcifications, Breast Cancer, Breast Cancer In Situ
on Nov 05, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopausal symptoms, menopause (What is menopause?) and was treated with Estraderm (View Usage). Patient had the following side effects: anxiety (What is anxiety?), arthritis (What is arthritis?), basal cell carcinoma, biopsy endometrium, blood cholesterol increased, blood triglycerides increased, breast calcifications, breast cancer (What is breast cancer?), breast cancer in situ. Estraderm dosage: 0.5 Mg, Unk. During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), ESTRACE (5 Mg, Unk) (View Estrace Review and Estrace Label ). Patient was hospitalized.

6444808-X | Abdominal Pain, Adrenal Mass, Anaemia, Arterial Occlusive Disease, Arthralgia, Arthritis, Asthma, Back Pain, Blood Cholesterol Increased
Patient was taking Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal mass, anaemia, arterial occlusive disease, arthralgia, arthritis (What is arthritis?), asthma (What is asthma?), back pain (What is back pain?), blood cholesterol increased on Nov 05, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 150.0 lb, was diagnosed with menopause (What is menopause?) and. Estraderm dosage: 0.05 Mg. During the same period patient was treated with ESTRADIOL (0.05mg) (View Estradiol Review and Estradiol Label ), MEDROXYPROGESTERONE ACETATE (2.5 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ESTROGEN NOS (View Estrogen Nos Review and Estrogen Nos Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (0.3 Mg, Qd) (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), PROMETRIUM (200 Mg, Unk) (View Prometrium Review and Prometrium Label ).

6443079-8 | Biliary Tract Disorder, Gastric Disorder, Hunger, Hyperphagia, Hypothyroidism, Weight Increased
Adverse event was reported on Nov 05, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 50 Unk, Unk) . Location: GERMANY , weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: biliary tract disorder, gastric disorder, hunger, hyperphagia, hypothyroidism, weight increased. During the same period patient was treated with IODINE (View Iodine Review and Iodine Label ).

6436409-4 | Abasia, Ankle Fracture, Arrhythmia, Biopsy Breast, Breast Calcifications, Breast Cancer In Situ, Breast Cyst, Breast Cyst Excision, Breast Fibrosis
on Nov 05, 2009 Female patient from UNITED STATES , weighting 257.9 lb, was diagnosed with menopause (What is menopause?), depression (What is depression?) and was treated with Estraderm (View Usage). Patient had the following side effects: abasia, ankle fracture, arrhythmia (What is arrhythmia?), biopsy breast, breast calcifications, breast cancer in situ, breast cyst, breast cyst excision, breast fibrosis. Estraderm dosage: 0.1mg Unk. During the same period patient was treated with CYCRIN (10mg Unk) (View Cycrin Review and Cycrin Label ), ZOLOFT (50mg Unk) (View Zoloft Review and Zoloft Label ), PHENTERMINE HYDROCHLORIDE (20 Unk, Unk) (View Phentermine Hydrochloride Review and Phentermine Hydrochloride Label ), PONDIMIN (30 Unk, Unk) (View Pondimin Review and Pondimin Label ), NOLVADEX (View Nolvadex Review and Nolvadex Label ), ZANTAC (Unk) (View Zantac Review and Zantac Label ), VITAMINS NOS (Unk) (View Vitamins Nos Review and Vitamins Nos Label ), ALLEGRA (Unk) (View Allegra Review and Allegra Label ). Patient was hospitalized and became disabled.

6436404-5 | Arthralgia, Biopsy, Biopsy Breast Abnormal, Breast Cancer, Breast Lump Removal, Breast Necrosis, Dyspnoea, Fibrocystic Breast Disease, Mammogram Abnormal
on Nov 05, 2009 Female patient from UNITED STATES , weighting 138.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: arthralgia, biopsy, biopsy breast abnormal, breast cancer (What is breast cancer?), breast lump removal, breast necrosis, dyspnoea, fibrocystic breast disease, mammogram abnormal. Estraderm dosage: 0.05 Mg/day, Unk. During the same period patient was treated with VIVELLE (Unk) (View Vivelle Review and Vivelle Label ), COMBIPATCH (0.05 Unk, Unk) (View Combipatch Review and Combipatch Label ), ESTRATEST (Unk) (View Estratest Review and Estratest Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), MPA (2.5 Mg, Unk) (View Mpa Review and Mpa Label ), PREMARIN (0.625 Mg/day, Unk) (View Premarin Review and Premarin Label ), PREMPRO (0.625 Mg/2.5 Mg/day, Unk) (View Prempro Review and Prempro Label ).

6429215-8 | Abdominal Pain, Endometrial Sarcoma, Endometriosis, Pollakiuria
Patient was taking Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), endometrial sarcoma, endometriosis (What is endometriosis?), pollakiuria on Oct 22, 2009 from UNITED STATES Additional patient health information: Female patient , 70 years of age, . Estraderm dosage: .

6420199-5 | Abdominal Pain, Amnesia, Anxiety, Biopsy Breast Abnormal, Bone Densitometry, Breast Cancer, Bronchitis, Carotid Artery Disease, Cataract Operation
Adverse event was reported on Oct 16, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.05 Mg/day, Twice Weekly) was diagnosed with menopausal symptoms and. Location: UNITED STATES , weighting 220.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), amnesia, anxiety (What is anxiety?), biopsy breast abnormal, bone densitometry, breast cancer (What is breast cancer?), bronchitis (What is bronchitis?), carotid artery disease (What is carotid artery disease?), cataract operation. During the same period patient was treated with PREMARIN (1.25 Mg To .625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Qd) (View Provera Review and Provera Label ), NORLUTATE (6 Mg, Unk) (View Norlutate Review and Norlutate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), MECLIZINE (View Meclizine Review and Meclizine Label ), DETROL (View Detrol Review and Detrol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6417273-6 | Cerebral Haemorrhage
on Oct 13, 2009 Female patient from GERMANY , 58 years of age, was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: cerebral haemorrhage. Estraderm dosage: Unk.

6404789-1 | Abdominal Pain, Amnesia, Anxiety, Biopsy Breast Abnormal, Bone Densitometry, Breast Cancer, Bronchitis, Carotid Artery Disease, Cataract Operation
on Oct 06, 2009 Female patient from UNITED STATES , weighting 220.0 lb, was diagnosed with menopausal symptoms and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), amnesia, anxiety (What is anxiety?), biopsy breast abnormal, bone densitometry, breast cancer (What is breast cancer?), bronchitis (What is bronchitis?), carotid artery disease (What is carotid artery disease?), cataract operation. Estraderm dosage: 0.05 Mg/day, Twice Weekly. During the same period patient was treated with PREMARIN (1.25 Mg To .625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Qd) (View Provera Review and Provera Label ), NORLUTATE (6 Mg, Unk) (View Norlutate Review and Norlutate Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ), GLIPIZIDE (View Glipizide Review and Glipizide Label ), MECLIZINE (View Meclizine Review and Meclizine Label ), DETROL (View Detrol Review and Detrol Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6401834-4 | Activities Of Daily Living Impaired, Blood Oestrogen Decreased, Dysuria, Economic Problem, Homeless, Mucosal Discolouration, Product Odour Abnormal, Product Outer Packaging Issue
Patient was taking Estraderm (View Usage). Patient had the following side effects: activities of daily living impaired, blood oestrogen decreased, dysuria, economic problem, homeless (What is homeless?), mucosal discolouration, product odour abnormal, product outer packaging issue on Oct 13, 2009 from UNITED STATES Additional patient health information: Female patient , 67 years of age, weighting 194.0 lb, was diagnosed with reproductive tract disorder, surgery (What is surgery?) and. Estraderm dosage: Apply 1patch 2xweek Top.

6384623-9 | Biliary Tract Disorder, Gastric Disorder, Hunger, Hyperphagia, Hypothyroidism, Weight Increased
Adverse event was reported on Sep 21, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 50 Unk, Unk) was diagnosed with surgery (What is surgery?) and. Location: GERMANY , weighting 123.5 lb, After Estraderm was administered, patient had the following side effects: biliary tract disorder, gastric disorder, hunger, hyperphagia, hypothyroidism, weight increased. During the same period patient was treated with IODINE (View Iodine Review and Iodine Label ).

6376591-0 | Osteoporosis
on Sep 15, 2009 Female patient from CANADA , 55 years of age, was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: osteoporosis (What is osteoporosis?). Estraderm dosage: 50.

6360936-1 | Osteoporosis
on Sep 10, 2009 Female patient from CANADA , 55 years of age, was treated with Estraderm (View Usage). Patient had the following side effects: osteoporosis (What is osteoporosis?). Estraderm dosage: 50.

6326704-1 | Hot Flush, Phlebitis, Tachycardia
Patient was taking Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: hot flush, phlebitis, tachycardia on Aug 17, 2009 from CANADA Additional patient health information: Female patient , 58 years of age, . Estraderm dosage: 25 Unk, Unk. During the same period patient was treated with PROGESTERONE (2.5 Mg, Unk) (View Progesterone Review and Progesterone Label ).

6311509-8 | Hot Flush, Phlebitis, Tachycardia
Adverse event was reported on Aug 04, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 25 Unk, Unk) . Location: CANADA , 58 years of age, Patient experienced the following unwanted or unexpected effects: hot flush, phlebitis, tachycardia. During the same period patient was treated with PROGESTERONE (2.5 Mg, Unk) (View Progesterone Review and Progesterone Label ).

6253886-2 | Abdominal Pain, Adrenal Mass, Anaemia, Arterial Occlusive Disease, Breast Calcifications, Breast Cancer, Breast Fibrosis, Breast Mass
on Jun 25, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), adrenal mass, anaemia, arterial occlusive disease, breast calcifications, breast cancer (What is breast cancer?), breast fibrosis, breast mass. Estraderm dosage: 0.05 Mg. During the same period patient was treated with ESTRADIOL (0.05mg) (View Estradiol Review and Estradiol Label ), MEDROXYPROGESTERONE ACETATE (2.5 Mg, Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ), ESTROGEN NOS (View Estrogen Nos Review and Estrogen Nos Label ), PREMPRO (View Prempro Review and Prempro Label ), PREMARIN (0.3 Mg, Qd) (View Premarin Review and Premarin Label ), PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), PROMETRIUM (200 Mg, Unk) (View Prometrium Review and Prometrium Label ).

6247721-6 | Ageusia, Anosmia, Application Site Reaction, Dyspnoea, Erythema, Feeling Hot, Hyperhidrosis, Inflammation, Insomnia
on Jun 17, 2009 Female patient from BRAZIL , weighting 174.2 lb, was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: ageusia, anosmia, application site reaction, dyspnoea, erythema, feeling hot, hyperhidrosis, inflammation, insomnia. Estraderm dosage: 100 Mcg. During the same period patient was treated with CLIANE (View Cliane Review and Cliane Label ).

6210292-4 | Colitis Ischaemic
Patient was taking Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: colitis ischaemic on May 29, 2009 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 165.0 lb, was diagnosed with endometriosis (What is endometriosis?), hysterectomy (What is hysterectomy?), migraine (What is migraine?) and. Estraderm dosage: 1 Daily Transdermal 12 Years --until April '07. During the same period patient was treated with IMITREX (1-2 Daily As Needed Po 11 Years--current) (View Imitrex Review and Imitrex Label ). Patient was hospitalized.

6186218-9 | Ageusia, Anosmia, Application Site Reaction, Dyspnoea, Erythema, Feeling Hot, Hyperhidrosis, Inflammation, Insomnia
Adverse event was reported on Apr 29, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 100 Mcg) . Location: BRAZIL , weighting 174.2 lb, Patient had the following side effects: ageusia, anosmia, application site reaction, dyspnoea, erythema, feeling hot, hyperhidrosis, inflammation, insomnia. During the same period patient was treated with CLIANE (View Cliane Review and Cliane Label ).

6184118-1 | Arthralgia, Aspiration Breast, Blood Pressure Decreased, Cutis Laxa, Depression, Dermatitis Bullous, Eyelid Disorder, Fluid Retention
on Apr 28, 2009 Female patient from BRAZIL , 62 years of age, weighting 125.7 lb, was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: arthralgia, aspiration breast, blood pressure decreased, cutis laxa, depression (What is depression?), dermatitis bullous, eyelid disorder, fluid retention. Estraderm dosage: 25 Mcg.

6158137-5 | Abdominal Distension, Basal Cell Carcinoma, Breast Calcifications, Breast Cancer Stage I, Breast Mass, Depression, Diverticulum, Haemorrhoids, Hot Flush
on Apr 15, 2009 Female patient from UNITED STATES , weighting 125.0 lb, was diagnosed with menopause (What is menopause?), osteoporosis (What is osteoporosis?), arthritis (What is arthritis?), hiatus hernia and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal distension, basal cell carcinoma, breast calcifications, breast cancer stage i, breast mass, depression (What is depression?), diverticulum, haemorrhoids, hot flush. Estraderm dosage: 0.05mg Twice Weekly Days 1-25. During the same period patient was treated with PREMPRO (0.625/2.5mg) (View Prempro Review and Prempro Label ), SEX HORMONES AND MODULATORS OF THE GENI. SYS. (View Sex Hormones And Modulators Of The Geni. Sys. Review and Sex Hormones And Modulators Of The Geni. Sys. Label ), CELEBREX (200mg Qd) (View Celebrex Review and Celebrex Label ), RANITIDINE (150mg Unk) (View Ranitidine Review and Ranitidine Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ), FOSAMAX (View Fosamax Review and Fosamax Label ), CALCIUM (View Calcium Review and Calcium Label ), PROVERA (2.5mg Days 1-25) (View Provera Review and Provera Label ).

6089599-X | Application Site Erythema, Application Site Pruritus, Endodontic Procedure, Skin Discolouration, Tooth Infection
Patient was taking Estraderm (View Usage). Patient had the following side effects: application site erythema, application site pruritus, endodontic procedure, skin discolouration, tooth infection on Feb 12, 2009 from BRAZIL Additional patient health information: Female patient , 52 years of age, weighting 125.7 lb, was diagnosed with infection (What is infection?) and. Estraderm dosage: 50 Mcg, Adhesive Replacement 2 Times/week. During the same period patient was treated with CELEBRA (200 Mg, 2 Tabs Per Day) (View Celebra Review and Celebra Label ), AMOXICILLIN (500 Mg, Q8h) (View Amoxicillin Review and Amoxicillin Label ).

6087553-5 | Arthralgia, Aspiration Breast, Blood Pressure Decreased, Cutis Laxa, Depression, Dermatitis Bullous, Eyelid Disorder, Fluid Retention, Gait Disturbance
Adverse event was reported on Feb 13, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 25 Mcg) . Location: BRAZIL , 62 years of age, weighting 125.7 lb, After Estraderm was administered, patient had the following side effects: arthralgia, aspiration breast, blood pressure decreased, cutis laxa, depression (What is depression?), dermatitis bullous, eyelid disorder, fluid retention, gait disturbance.

6067211-3 | Amenorrhoea, Arthritis, Asthenia, Atrial Fibrillation, Back Pain, Basedow's Disease, Biopsy Endometrium, Blood Cholesterol Increased, Blood Triglycerides Increased
on Jan 27, 2009 Female patient from UNITED STATES , weighting 182.0 lb, was diagnosed with menopause (What is menopause?), cardiovascular event prophylaxis, uterine cancer (What is uterine cancer?), hypercholesterolaemia and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: amenorrhoea, arthritis (What is arthritis?), asthenia, atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), basedow's disease, biopsy endometrium, blood cholesterol increased, blood triglycerides increased. Estraderm dosage: 0.1 Mg, Unk. During the same period patient was treated with VIVELLE DOT (0.1 Mg, Unk) (View Vivelle-dot Review and Vivelle-dot Label ), PROVERA (5 Mg, Unk) (View Provera Review and Provera Label ), TRICOR (145 Mg, Qd) (View Tricor Review and Tricor Label ). Patient was hospitalized.

6066202-6 | Arrhythmia, Back Pain, Breast Cancer, Breast Disorder, Breast Reconstruction, Cardiac Disorder, Cardiac Valve Disease, Depression, Face Injury
on Jan 27, 2009 Female patient from UNITED STATES , weighting 198.0 lb, was diagnosed with menopausal symptoms, hypertension, depression (What is depression?), social phobia and was treated with Estraderm (View Usage). Patient had the following side effects: arrhythmia (What is arrhythmia?), back pain (What is back pain?), breast cancer (What is breast cancer?), breast disorder, breast reconstruction (What is breast reconstruction?), cardiac disorder, cardiac valve disease, depression (What is depression?), face injury. Estraderm dosage: Unk Biw. During the same period patient was treated with PREMPRO (.625/2.5mg Qd) (View Prempro Review and Prempro Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYTOXAN (View Cytoxan Review and Cytoxan Label ), TAMOXIFEN CITRATE (10mg Bid) (View Tamoxifen Citrate Review and Tamoxifen Citrate Label ), LOPRESSOR (Unk, Unk) (View Lopressor Review and Lopressor Label ), PROZAC (Unk, Unk) (View Prozac Review and Prozac Label ), CELEXA (View Celexa Review and Celexa Label ), FEMARA (View Femara Review and Femara Label ).

6066198-7 | Arthralgia, Breast Calcifications, Breast Cancer Stage Ii, Breast Cyst, Colonic Polyp, Diverticulum, Diverticulum Intestinal, Erythema, Fall
Patient was taking Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: arthralgia, breast calcifications, breast cancer stage ii, breast cyst, colonic polyp (What is colonic polyp?), diverticulum, diverticulum intestinal, erythema, fall (What is fall?) on Jan 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 115.2 lb, was diagnosed with menopause (What is menopause?), migraine (What is migraine?) and. Estraderm dosage: . During the same period patient was treated with MPA (2.5mg Unk) (View Mpa Review and Mpa Label ), PROVERA (View Provera Review and Provera Label ), PREMARIN (0.625mg Unk) (View Premarin Review and Premarin Label ), PREMPRO (.625mg Unk) (View Prempro Review and Prempro Label ), CYCRIN (View Cycrin Review and Cycrin Label ), PROMETRIUM (100mg Unk) (View Prometrium Review and Prometrium Label ), IMITREX (25 Mg, Unk) (View Imitrex Review and Imitrex Label ), NORFLEX (100mg Unk) (View Norflex Review and Norflex Label ).

6066194-X | Application Site Pain, Blood Cholesterol Increased, Breast Cyst, Cystitis, Knee Arthroplasty, Ph Body Fluid Abnormal, Platelet Count Increased, Surgery, Tendon Rupture
Adverse event was reported on Jan 27, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.05 Unk, Unk) . Location: UNITED STATES , 68 years of age, Patient experienced the following unwanted or unexpected effects: application site pain, blood cholesterol increased, breast cyst, cystitis, knee arthroplasty, ph body fluid abnormal, platelet count increased, surgery (What is surgery?), tendon rupture.

6066191-4 | Anxiety, Aortic Valve Incompetence, Aortic Valve Sclerosis, Arrhythmia, Blood Thyroid Stimulating Hormone Abnormal, Breast Cancer, Breast Cellulitis, Breast Disorder, Breast Lump Removal
on Jan 27, 2009 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). Patient had the following side effects: anxiety (What is anxiety?), aortic valve incompetence, aortic valve sclerosis, arrhythmia (What is arrhythmia?), blood thyroid stimulating hormone abnormal, breast cancer (What is breast cancer?), breast cellulitis, breast disorder, breast lump removal. Estraderm dosage: 0.1mg Patch/2x Week. During the same period patient was treated with VIVELLE (0.05 Mg Patch/2xweek) (View Vivelle Review and Vivelle Label ), PROVERA (2.5 Mg, Qd) (View Provera Review and Provera Label ), PREMARIN (1.25 Mg, Bid) (View Premarin Review and Premarin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6066187-2 | Abasia, Ankle Fracture, Arrhythmia, Biopsy Breast, Breast Calcifications, Breast Cancer In Situ, Breast Cyst, Breast Cyst Excision, Breast Fibrosis
on Jan 27, 2009 Female patient from UNITED STATES , weighting 257.9 lb, was diagnosed with menopause (What is menopause?), depression (What is depression?) and was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: abasia, ankle fracture, arrhythmia (What is arrhythmia?), biopsy breast, breast calcifications, breast cancer in situ, breast cyst, breast cyst excision, breast fibrosis. Estraderm dosage: 0.1mg Unk. During the same period patient was treated with CYCRIN (10mg Unk) (View Cycrin Review and Cycrin Label ), ZOLOFT (50mg Unk) (View Zoloft Review and Zoloft Label ), PHENTERMINE (20 Unk, Unk) (View Phentermine Review and Phentermine Label ), PONDIMIN (30 Unk, Unk) (View Pondimin Review and Pondimin Label ), NOLVADEX (View Nolvadex Review and Nolvadex Label ). Patient was hospitalized and became disabled.

6066183-5 | Angiopathy, Asthenia, Biopsy, Breast Calcifications, Breast Cancer Metastatic, Breast Cancer Recurrent, Breast Lump Removal, Breast Mass, Cardiac Disorder
Patient was taking Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: angiopathy, asthenia, biopsy, breast calcifications, breast cancer metastatic, breast cancer recurrent, breast lump removal, breast mass, cardiac disorder on Jan 27, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, was diagnosed with depression (What is depression?) and. Estraderm dosage: . During the same period patient was treated with PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (10 Mg, Unk) (View Provera Review and Provera Label ), PREMPRO (Unk, Unk) (View Prempro Review and Prempro Label ), ZOLOFT (25 Mg, Qd) (View Zoloft Review and Zoloft Label ), ALLEGRA (View Allegra Review and Allegra Label ). Patient was hospitalized.

6065249-3 | Abdominal Pain, Anxiety, Application Site Reaction, Arthritis, Aspiration Biopsy, Bone Giant Cell Tumour, Breast Cancer In Situ, Breast Cancer Recurrent, Breast Cancer Stage I
Adverse event was reported on Jan 27, 2009 by a Female patient taking Estraderm (View Usage) (Dosage: 0.05 Mg, 2x/wk) was diagnosed with menopausal symptoms and. Location: UNITED STATES , weighting 135.0 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), anxiety (What is anxiety?), application site reaction, arthritis (What is arthritis?), aspiration biopsy, bone giant cell tumour, breast cancer in situ, breast cancer recurrent, breast cancer stage i. During the same period patient was treated with PREMPRO (625/2.5 Mg) (View Prempro Review and Prempro Label ), PREMARIN (0.625 Mg, Unk) (View Premarin Review and Premarin Label ), PROVERA (5/2.5 Mg Day 1-14) (View Provera Review and Provera Label ), OGEN (View Ogen Review and Ogen Label ), XANAX (View Xanax Review and Xanax Label ), EVISTA (Unk) (View Evista Review and Evista Label ), PROZAC (40 Mg, Unk) (View Prozac Review and Prozac Label ). Patient was hospitalized.

6059466-6 | Anxiety, Aortic Valve Incompetence, Aortic Valve Sclerosis, Arrhythmia, Blood Thyroid Stimulating Hormone Abnormal, Breast Cancer, Breast Cellulitis, Breast Disorder, Breast Lump Removal
on Jan 22, 2009 Female patient from UNITED STATES , weighting 162.0 lb, was diagnosed with menopause (What is menopause?) and was treated with Estraderm (View Usage). After Estraderm was administered, patient had the following side effects: anxiety (What is anxiety?), aortic valve incompetence, aortic valve sclerosis, arrhythmia (What is arrhythmia?), blood thyroid stimulating hormone abnormal, breast cancer (What is breast cancer?), breast cellulitis, breast disorder, breast lump removal. Estraderm dosage: 0.1mg Patch/2x Week. During the same period patient was treated with VIVELLE (0.05 Mg Patch/2xweek) (View Vivelle Review and Vivelle Label ), PROVERA (2.5 Mg, Qd) (View Provera Review and Provera Label ), PREMARIN (1.25 Mg, Bid) (View Premarin Review and Premarin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6056493-X | Appendicectomy, Appendicitis, Biopsy Breast Abnormal, Blood Cholesterol Increased, Breast Cancer, Breast Cyst, Breast Mass, Bronchoalveolar Lavage Abnormal, Cataract
on Jan 22, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with menopause (What is menopause?), hypothyroidism and was treated with Estraderm (View Usage). Patient experienced the following unwanted or unexpected effects: appendicectomy, appendicitis (What is appendicitis?), biopsy breast abnormal, blood cholesterol increased, breast cancer (What is breast cancer?), breast cyst, breast mass, bronchoalveolar lavage abnormal, cataract (What is cataract?). Estraderm dosage: . During the same period patient was treated with PROVERA (2.5 Mg, Unk) (View Provera Review and Provera Label ), CLIMARA (View Climara Review and Climara Label ), PREMPRO (0.625 Mg/25 Mg) (View Prempro Review and Prempro Label ), SYNTHROID (112 Ug, Qd) (View Synthroid Review and Synthroid Label ), MORVAN (View Morvan Review and Morvan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LEVOXYL (0.1 Mg, Unk) (View Levoxyl Review and Levoxyl Label ), UNIVASC (7.5 Mg, Unk) (View Univasc Review and Univasc Label ). Patient was hospitalized.

6036813-2 | Abasia, Ankle Fracture, Arrhythmia, Breast Calcifications, Breast Cancer In Situ, Breast Cyst, Breast Cyst Excision, Breast Fibrosis, Breast Inflammation
Patient was taking Estraderm (View Usage). Patient had the following side effects: abasia, ankle fracture, arrhythmia (What is arrhythmia?), breast calcifications, breast cancer in situ, breast cyst, breast cyst excision, breast fibrosis, breast inflammation on Jan 05, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 257.9 lb, was diagnosed with menopause (What is menopause?), depression (What is depression?) and. Estraderm dosage: 0.1mg Unk. During the same period patient was treated with CYCRIN (10mg Unk) (View Cycrin Review and Cycrin Label ), ZOLOFT (50mg Unk) (View Zoloft Review and Zoloft Label ), ADIPEX (20 Unk, Unk) (View Adipex Review and Adipex Label ), PONDIMIN (30 Unk, Unk) (View Pondimin Review and Pondimin Label ), NOLVADEX (View Nolvadex Review and Nolvadex Label ). Patient was hospitalized and became disabled.